AGP Picks
View all

Dr. David Shuman tops 100 VetStem Cell Therapy cases

an hour ago
Dr. David Shuman tops 100 VetStem Cell Therapy cases
By AI, Created 13:00 UTC, Nov 18, 2026, AGP -

Westside Animal Hospital veterinarian Dr. David Shuman has surpassed 100 VetStem Cell Therapy cases after using the regenerative treatment since 2008. The milestone highlights continued interest in stem cell options for pets with orthopedic injuries and degenerative conditions.

Why it matters: - Dr. David Shuman’s 100-plus VetStem cases show long-term adoption of regenerative veterinary care in a community practice. - The milestone reflects growing use of autologous stem cell treatment for pets with orthopedic injuries and degenerative disease.

What happened: - Dr. Shuman of Westside Animal Hospital in Santa Cruz, California, surpassed 100 cases using VetStem Cell Therapy. - Dr. Shuman has used VetStem Cell Therapy since 2008. - Dr. Shuman has practiced veterinary medicine for more than 30 years. - Dr. Shuman earned a Doctor of Veterinary Medicine degree from the University of California, Davis in 1993. - Dr. Shuman opened Westside Animal Hospital in 1999. - Westside Animal Hospital serves pets and families in Santa Cruz and surrounding communities.

The details: - VetStem Cell Therapy uses a patient’s own stem cells. - The process starts with collecting a small sample of the patient’s fat tissue. - VetStem processes the tissue and returns the stem cells to the veterinarian for administration. - One example of Dr. Shuman’s work involved Vader, a dog treated with stem cells for cruciate ligament injuries. - VetStem Cell Therapy is used for conditions such as osteoarthritis, torn ligaments and injured tendons in dogs, cats and horses. - The therapy may help reduce pain, inflammation and scar tissue formation. - The therapy may also help restore range of motion and support repair of tendon, ligament and joint tissues. - Surveys completed by veterinarians and owners found that more than 80% of dogs treated for orthopedic conditions experienced improved quality of life.

Between the lines: - VetStem’s recognition of Dr. Shuman signals the company’s effort to showcase veterinarians who have integrated regenerative medicine into routine care. - Dr. Shuman’s milestone suggests sustained demand for alternatives to conventional treatment for chronic and traumatic musculoskeletal problems.

What’s next: - VetStem said it remains focused on developing clinically practical and affordable veterinary solutions. - The company continues to offer veterinarians autologous stem cell processing from patients’ own fat tissue, along with other regenerative modalities. - VetStem also holds exclusive global veterinary licenses to a portfolio of issued patents in regenerative medicine.

The bottom line: - Dr. Shuman’s 100-case milestone underscores how regenerative medicine has moved further into everyday veterinary practice.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

One World Daily Brief

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

One World Daily Brief

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.